Navigation Links
Santarus to Webcast Analyst Day and Investor Briefing Presentation on May 13
Date:5/8/2009

SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Santarus, Inc. (Nasdaq: SNTS) today announced that a live audio webcast and accompanying slide presentation will be provided for its analyst day and investor briefing event "Santarus: What's New?".

Details of the event are as follows:

          What:     Santarus: What's New? Analyst Day and Investor Briefing

          When:     Wednesday, May 13, 2009 at 4:15 p.m. Eastern time

          Where:    www.santarus.com (under the Investor Relations link)

AGENDA

Welcome

Martha Hough, Vice President, Finance & Investor Relations, Santarus, Inc.

Santarus - What's New?

Gerald Proehl, President, Chief Executive Officer & Director, Santarus, Inc.

Commercial Update - ZEGERID(R)/GLUMETZA(R) and Overview of Lower GI Markets

William Denby, Senior Vice President, Commercial Operations, Santarus, Inc.

MMX(R) Technology - The Benefits of Targeted Delivery to the Colon

Dr. Luigi Moro, Chief Scientific Officer, Cosmo Pharmaceuticals

Inflammatory Bowel Disease - A New Horizon

Dr. Simon Travis, Consultant Gastroenterologist, John Radcliffe Hospital, Oxford, United Kingdom; Chairman of the Scientific Committee of the European Crohn's and Colitis Organization

Budesonide MMX(R) - Clinical Development Program in Ulcerative Colitis

Dr. E. David Ballard II, Senior Vice President, Clinical Research & Medical Affairs, Santarus, Inc.

Traveler's Diarrhea - #1 Health Risk for Travelers to Developing Countries

Dr. Robert Steffen, Professor Emeritus, University of Zurich Centre for Travel Medicine; Director, World Health Organization Collaborating Center for Travelers' Health

Rifamycin SV MMX(R) - Clinical Development Program in Traveler's Diarrhea

Dr. E. David Ballard II, Senior Vice President, Clinical Research & Medical Affairs, Santarus, Inc.

Summary/Question & Answer Session

Gerald Proehl, President, Chief Executive Officer & Director, Santarus, Inc.

          How:       Live over the Internet -- Simply log on to the Investor
                     Relations section of the company's Web site at
                     www.santarus.com

About Santarus

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians. The company's current commercial efforts are focused on ZEGERID(R) (omeprazole/sodium bicarbonate) Capsules and Powder for Oral Suspension, which are indicated for the treatment of certain upper GI diseases and disorders, and on GLUMETZA(R) (metformin hydrochloride extended-release tablets), which are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Santarus is also developing two late-stage lower GI product candidates, budesonide MMX(R) and rifamycin SV MMX(R) for the U.S. market. Budesonide MMX is being investigated in two multi-center Phase III clinical trials for the induction of remission of mild or moderate active ulcerative colitis. Rifamycin SV MMX has been investigated in a Phase II clinical program in traveler's diarrhea. More information about Santarus is available on the company's Web site at www.santarus.com.

Minimum Requirements to listen to broadcast:

The Windows Media Player software, downloadable free from http://www.microsoft.com/windows/windowsmedia/default.aspx and at least a 56Kbps connection to the Internet. If you experience problems listening to the webcast, send an e-mail to: webcast@multivu.com.


'/>"/>
SOURCE Santarus, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mettler-Toledo International Inc. Announces Webcast of Presentation at Bank of America and Merrill Lynch Health Care Conference
2. Webcast Alert: Air Methods to Announce First Quarter 2009 Financial Results
3. Webcast Alert: Release of Economic Analysis Revealing $734 Billion in Savings Produced by Using Generic Medicines in 1999 - 2008
4. Gen-Probe to Webcast Two Upcoming Investor Presentations
5. Volcano Corporation Presentation at Bank of America/Merrill Lynch Conference to be Webcast
6. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 7, 2009
7. Sunrise to Host Conference Call and Webcast to Discuss First-Quarter 2009 Financial Results
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
9. Thoratec Schedules First Quarter Conference Call, Webcast
10. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
11. Cepheid to Webcast Upcoming Financial Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology: